SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-07-054286
Filing Date
2007-10-15
Accepted
2007-10-15 16:53:48
Documents
9
Period of Report
2007-07-31

Document Format Files

Seq Description Document Type Size
1 v090113_10k.htm 10-K 7261128
2 GRAPHIC chart.jpg GRAPHIC 34129
3 v090113_ex10-27.htm EX-10.27 6428
4 v090113_ex21.htm EX-21 11236
5 v090113_ex23-1.htm EX-23.1 3359
6 v090113_ex23-2.htm EX-23.2 3939
7 v090113_ex31-1.htm EX-31.1 24308
8 v090113_ex31-2.htm EX-31.2 24003
9 v090113_ex32.htm EX-32 8798
  Complete submission text file 0001144204-07-054286.txt   7391800
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 000-25169 | Film No.: 071172347
SIC: 2834 Pharmaceutical Preparations